SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-23-005067
Filing Date
2023-02-28
Accepted
2023-02-28 16:06:30
Documents
82
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K fate-20221231.htm   iXBRL 10-K 4660575
2 EX-21.1 fate-ex21_1.htm EX-21 16297
3 EX-23.1 fate-ex23_1.htm EX-23 6592
4 EX-31.1 fate-ex31_1.htm EX-31 14636
5 EX-31.2 fate-ex31_2.htm EX-31 16305
6 EX-32.1 fate-ex32_1.htm EX-32 9604
7 EX-32.2 fate-ex32_2.htm EX-32 9874
8 GRAPHIC img141963902_0.jpg GRAPHIC 40645
  Complete submission text file 0000950170-23-005067.txt   16381768

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fate-20221231.xsd EX-101.SCH 85352
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fate-20221231_pre.xml EX-101.PRE 529147
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fate-20221231_cal.xml EX-101.CAL 54913
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fate-20221231_lab.xml EX-101.LAB 714972
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fate-20221231_def.xml EX-101.DEF 348878
76 EXTRACTED XBRL INSTANCE DOCUMENT fate-20221231_htm.xml XML 3539176
Mailing Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131
Business Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

IRS No.: 651311552 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36076 | Film No.: 23685158
SIC: 2836 Biological Products, (No Diagnostic Substances)